KDA
- Current
- Browse
- Collections
-
For contributors
- For Authors
- Instructions for authors
- Article processing charge
- e-submission
- For Reviewers
- Instructions for reviewers
- How to become a reviewer
- Best reviewers
- For Readers
- Readership
- Subscription
- Permission guidelines
- About
- Editorial policy
Search
- Page Path
- HOME > Search
Editorial
- The Beneficial Effect of Glycemic Control against Adverse Outcomes in Patients with Type 2 Diabetes Mellitus and Chronic Kidney Disease
- Dong-Hwa Lee
- Diabetes Metab J. 2023;47(4):484-486. Published online July 27, 2023
- DOI: https://doi.org/10.4093/dmj.2023.0165
- 2,479 View
- 138 Download
- 1 Web of Science
- 1 Crossref
-
PDF
PubReader 
ePub -
Citations
Citations to this article as recorded by
- Diagnostic Significance of Elabela, FABP1, and FABP2 as Biomarkers of Diabetic Nephropathy in Type 2 Diabetic Patients
Samah M. Mohamed, Kholoud S. Ramadan, Ahmed A. Saedii, Ehab A. Ibrahim
Indian Journal of Clinical Biochemistry.2024;[Epub] CrossRef
- Diagnostic Significance of Elabela, FABP1, and FABP2 as Biomarkers of Diabetic Nephropathy in Type 2 Diabetic Patients
First
Prev
